© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
Home 2014
Archives
Study: New drug effective for ACE-inhibitor angioedema
A Phase II study found that patients with ACE inhibitor-induced angioedema who received ecallantide were more likely to be discharged sooner than those treated...
Study: Pradaxa reduces stroke and death, but increases GI bleeding compared to warfarin
According to a study from the U.S. Food and Drug Administration (FDA), Pradaxa (dabigatran), in comparison to warfarin, was associated with a lower risk...
FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer...
Study: Marijuana use in young adults may cause brain changes
The size and shape of two brain regions (the nucleus accumbens and the amygdala) involved in emotion and motivation may differ in young adults...
Study: Phase II drugs may help prevent migraine attacks
Two studies presented at the American Academy of Neurology’s 66th Annual Meeting, 2014, may offer hope to people with migraines. The two phase II...
FDA approves Topamax for migraine prevention in adolescents
On March 28, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention of migraine headaches in adolescents ages 12 to 17. This...
FDA approves Tanzeum to treat type 2 diabetes
On April 3, the U.S. Food and Drug Administration (FDA) approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise,...
Study: CDC says improved antibiotic prescribing would reduce resistance
A study from the Centers for Disease Control and Prevention (CDC) reports that potential harm from antibiotic resistance can be reduced through formal programs...
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces
lost liver functions.
Continuing use of statins may reduce risk of delirium in ICU patients
Continuing statin therapy in patients already on this therapy is associated with a lower daily risk of delirium in ICU patients, according to a...
Study: Use of antibiotics to prevent complications from respiratory infections in children isn’t supported
An analysis published in The Cochrane Report says current evidence doesn’t provide strong support for using antibiotics to prevent ear infections and pneumonia in...
Study: Psychological adverse effects of antidepressants
Thoughts of suicide, sexual difficulties and emotional numbness as a result of anti-depressants may be more widespread than previously thought, according to a study...